Patient Centricity Key To Clinical Trial Participation

Over the past two years, the COVID-19 pandemic served as a focal point for the clinical trial landscape. However, many studies beyond the scope of coronavirus made major developments in the trial space, from Crohn’s disease to autoimmune diseases and Alzheimer’s. But in order to allow these trials to progress and provide the crucial data needed to make such strides, the industry needs to shift towards increasing patient-centric approaches to clinical trials.

Patient centricity allows the patient voice to be incorporated throughout the clinical trial process. Some initial steps in exploring this method include hosting focus groups, conducting live protocol simulations, working with patient advocacy organizations, and analyzing real-world data. By incorporating the patient perspective into each stage of the process, sponsors would increase enrollment as well as retention in clinical trials.